Positive Phase 2a Result The Phase 21...
Tiziana Life Sciences (NASDAQ: TLSA): Major MS Trial Success Puts Intranasal Foralumab in the Spotlight as Global Pharma Talks Begin
read more
Positive Phase 2a Result The Phase 21...
November 2, 2026 | Clinical Trial...